Considering the mechanistic overlap in the development and progression of CKD in type 1 and type 2 diabetes, there exists a strong rationale for simultaneously developing novel CKD therapies for use in both type 1 diabetes and type 2 diabetes and studying the repurposing of existing type 2 diabetes CKD therapies for the treatment of CKD in people with type 1 diabetes
Early research suggested GIP promoted fat storage
van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM
Androgen levels fall
Were Here to Help Our mission is to provide thoughtful, personalized care, and that doesnt change
We treat both men & women for hair growth, peptide therapy, GLP-1 weight loss, and longevity care, all from the comfort of home